Bioabsorbable Vascular Scaffold: A Revolution in Coronary Intervention
نویسندگان
چکیده
منابع مشابه
Coronary Artery Aneurysm After Everolimus-Eluting Bioabsorbable Vascular Scaffold Implantation.
A mong the rare complications after percutaneous coronary intervention, coronary artery aneurysms (CAA) reportedly have an incidence of 0.3% to 6.0%. The detection of CAAs vary from 3 days to up to 4 years after drug-eluting stent (DES) and from 6 days to up to 6 years after baremetal stents (BMS) implantation. Associated factors include residual dissection and deep arterial wall injury caused ...
متن کاملAcute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome.
events associated with testosterone administration. N Engl J Med 2010;36:109–122. 47. Viigimaa M, Doumas M, Vlachopoulos C, Anyfanti P, Wolf J, Narkiewicz K, Mancia G. European Society of Hypertension Working Group on Sexual Dysfunction. Hypertension and sexual dysfunction: time to act. J Hypertens 2011;29: 403–407. 48. Apostolo A, Vignati C, Brusoni D, Cattadori G, Contini M, Veglia F, Magrı̀ D...
متن کاملScaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.
OBJECTIVES The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) by conducting a systematic review and meta-analysis. BACKGROUND PCI with BVS placement holds great potential, but concern has recently been raised regar...
متن کاملBioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial
Drug-eluting stents have significantly improved the long-term outcomes of percutaneous coronary intervention (PCI) by decreasing the excessive growth of neointima. However, conventional stents have some limitations. PCI with a bioresorbable vascular scaffold (BVS) has emerged as an alternative since the presence of the prosthesis in the coronary artery is transient. A US Food and Drug Administr...
متن کاملLong-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold
Background: Bioresorbable vascular scaffolds (BVS) were developed to improve the long-term results of percutaneous coronary intervention, restoring vasomotion. Objectives: To report very late follow-up of everolimus-eluting Absorb BVS (Abbott Vascular, Santa Clara, USA) in our center. Methods: Observational retrospective study, in a single Brazilian center, from August 2011 to October 2013,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiovascular Journal
سال: 2014
ISSN: 2309-6357,2071-0917
DOI: 10.3329/cardio.v6i2.18359